Pay in installments of $6.53 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 19 - Jun 24
For Your Every Summer RSVP, with Code: SUMMER15
Description
Get GLP 1s for Weight Loss Online GoodRx GLP 1 Weight Loss Gummies: Needle Free Appetite & Metabolism Support Regenerative Health Institute Alluvi Vls Retatrutide Pendulum Therapeutics Introduces GLP 1 Probiotic




Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.4 ★★★★★
Based on 168 reviews
Sort
Product Reviews
★★★★★ 5
Underwriting Multifamily
Format: Kindle
This book deserve a five star rating. It uses practical examples easy to follow. This well written book easy to understand. I recommend this book to any real estate investor.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 20, 2024
★★★★★ 5
Must Have Book for Investors or Sponsors/GPs wanting to Invest in Multifamily Properties!
Format: Paperback
If you understand the math and numbers associated with investing in real estate, this book will help you underwrite any multifamily property. Not only does Robert's book discuss how to gather the information needed for underwriting, he goes into detail on how sponsors can manipulate the numbers. This is a great book for knowledge on the pros and cons of varied partnership structures and how each can create an alignment of interest between limited partners (LPs) and general partners (GPs). Overall, this is a great easy read book.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 13, 2020
★★★★★ 4
Basic knowledge of underwriting is necessary to understand.
Format: Paperback
This is a great guide for underwriting multifamily deals for someone with some basic to moderate knowledge of underwriting. I am a new student to this field and have to stop and google some of the acronyms. For a future version, I think adding an extra page for the acronyms used, definition and equation would be helpful. I think that the font could be larger and darker. Adding mathematical formulas in the book would provide visualization as well. Rob can also provide a sample OM for the reader to use with his underwriting model and compare to his completed one. Again, I am a newbie so my review may change as I gain knowledge in this area. I enjoyed listening to Rob on Youtube/Podcast and hope to learn more from him.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 27, 2020
★★★★★ 5
Easy to understand and well organized
Format: Paperback
Author makes complex concepts feel approachable and easy to comprehend. The content is sufficient to be an introductory course
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 22, 2025
★★★★★ 5
great read for underwriters of multifamily deals
Format: Kindle
Rob lays out a succinct and thorough summary of his underwriting process, questions industry standards while sharing his opinions, and discusses risk management and analyses for deals during the underwriting process. Highly recommend for newer and more seasoned underwriters and investors to build or sharpen multifamily underwriting fundamentals and details. He also shares his model as the example.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 27, 2023
recommand products
GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes
23.69
MCT2D
25.59
GLP-1 Nutrition Support Guide | PDF | Weight Loss
28.14
GLP-1 Medications – Community Education
27.76
The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when clinically appropriate
23.88




